News
AbbVie Inc. (NYSE:ABBV) is one of the best stocks to buy for beginners now. In mid-May, AbbVie and ADARx Pharmaceuticals ...
Your DNA is continually damaged by sources both inside and outside your body. One especially severe form of damage called a ...
Using capillary gel electrophoresis, researchers from the National Institute of Health Sciences in Kanagawa, Japan studied the factors that optimize chain-length distribution analysis of messenger RNA ...
RNA gene scissors (CRISPR-Cas13) are gaining significant attention as a next-generation gene therapy with fewer side effects.
BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...
For a long time, scientists depended on luck to find new proteins. In 1840, for example, Friedrich Ludwig Hünefeld, a German ...
The recent downturn in biotech has battered Massachusetts’ world-renowned sector, and the political climate has only made it ...
Researchers in Australia use COVID-era mRNA technology to expose hidden HIV in white blood cells, offering hope for a future ...
The BioNTech SE acquisition of CureVac N.V. brings together complementary technologies, as both are developing mRNA ...
Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.
President Trump’s administration has slammed the brakes on development of messenger RNA (mRNA) vaccines, which proved their lifesaving potential during the COVID-19 pandemic but have come ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results